Kolon Life Science Inc (102940) — Capital Reinvestment Ratio
Kolon Life Science Inc (102940) has a Capital Reinvestment Ratio of 3.12x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩2.58 Billion) in capital expenditures (₩8.05 Billion). Check tangible equity quality of Kolon Life Science Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kolon Life Science Inc Capital Reinvestment Ratio (2011–2016)
This chart tracks Kolon Life Science Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Kolon Life Science Inc.
Annual Capital Reinvestment Ratio for Kolon Life Science Inc (2011–2016)
Year-by-year Capital Reinvestment Ratio for Kolon Life Science Inc from 2011 to 2016. See Kolon Life Science Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.57x | ₩28.11 Billion | ₩16.14 Billion | ▼ -21.5% |
| 2015 | 0.73x | ₩20.81 Billion | ₩15.22 Billion | ▼ -41.1% |
| 2014 | 1.24x | ₩12.10 Billion | ₩15.01 Billion | ▼ -52.5% |
| 2012 | 2.61x | ₩23.37 Billion | ₩61.01 Billion | ▲ +10.5% |
| 2011 | 2.36x | ₩11.65 Billion | ₩27.52 Billion | — |